Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists develop cancer-fighting robots
Magnified algae with magnetic coating.

Devices pave way for the development of new treatments

Scientists have developed tiny, remote-controlled robots that release cancer-fighting compounds. It is hoped that the robots may someday be used to diagnose and treat illness in areas of the human body that are difficult to reach.

Developed by an international team of researchers, the ‘micro-robots’ are coated in microscopic algae with non-harmful, biocompatible magnetic particles. The devices are about the size of a blood cell and can swim in biological fluids, such as dilute blood and gastric fluid.

In experiments with rats, scientists used magnets to guide the robots to sites in the stomach. They could be tracked in tissue close to the surface of the skin by imaging the algae’s natural luminescence. In harder-to-reach tissue, they could be tracked using an MRI scanner.

Besides delivering drugs to areas of the body that are hard-to-reach, scientists say the robots could also sense chemical changes linked to the onset of illness. This could one day make them useful as probes for remote diagnosis.

The devices biodegrade within the body and can take more or less time depending on the thickness of their manufactured coating.
Qi Zhou, of the University of Edinburgh’s School of Engineering, who worked on the study, said:

“A small-scale robot that can be remotely guided, is easily tracked and harmlessly biodegrades, potentially overcomes many of the challenges faced by minimally invasive therapies. We hope our discoveries will pave the way for the development of useful diagnostics or treatments.”

The study, published in Science Robotics, was carried out in collaboration with the Universities of Edinburgh and Manchester.

Image (C) Yan et al Science Robotics 2017.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'